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for relapse. Our aim was to compare the incidence of 
resistance to 2nd generation FQ, such as ofloxacin, 
pefloxacin and ciprofloxacin, in bacteria isolated from 
blood cultures of patients who received (group 1) and in 
those who not received PQF (group 2) during the period 
1996-2000. 
Results: Group 1 consisted of 102 febrile episodes in 76 
pts. with a median age of 7.9 years. 72.5% of episodes 
were in HSCT pts. and 23.5 % in relapsed pts. They were 
classified as MID in 24%, as CID in 13 % and as FUO in 
63% of cases. Septic shock was present in 5/102 episodes 
(5%). Early mortality (within 30 days) was observed in 
3/76 pts (4%). The strains isolated from blood were 19 
(13 G+, 5 G-, 1 fungus) and 13 were tested for FQ 
susceptibility: resistance to FQ was observed in 3/S 
G+(37%) and 3/5 G- (60%) , respectively. 
Group 2 consisted of 916 febrile episodes in 341 pts 
with a median age of 5.2 years. Only a minority of 
episodes were in HSCT pts (5%) or in relapsed pts 
(18%). They were classified as MID in 25%, as CID in 
11% and as FUO in 64% of cases. Septic shock was 
present in 23/916 episodes (2.5%). Early mortality was 
observed in 51/341 (15%) pts. The strains isolated from 
blood were 186 (105 G+, 63 G- and 18 fungi) and 156 
were tested for FQ susceptibility: resistance to FQ 
was found in 22/95 G+ (23%) and 4/61 G- (6.5%), 
respectively. 
Conclusions: this data show a major incidence of 
sistemic infections by G- FQ resistent strain in patients 
who were on PFQ although that has not been translated 
in a major incidence of clinically or microbiologically 
demonstrated infections or in a major mortality rate. G+ 
strains appeared intrinsically more resistent to FQ 
because a high rate of resistence was found also in pts 
who were not receiving PFQ. Prospective randomized 
studies are needed to define the role of PFQ prophylaxis 
in reducing severe infections and early mortality in high- 
risk patients. 
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Introduction: The differences in antifungal susceptibility 
of C. glabrata associated with bloodstream invasion, 
infection, and colonization are uncertain. Most systemic 
candidiasis arises from host’s endogenous flora so it is 
important to evaluate the prevalence of drug resistance 
among organisms comprising yeast reservoir to deter- 
mine appropriate prophylactic, preemptive, and empiric 
therapy, especially in high-risk settings. 
Methods: Evaluation of all clinical yeast isolates during 
1998 to 1999 from three large teaching hospitals in New 
York City was performed prospectively. Candida spp. re- 
identification (under code) and susceptibility according 
to NCCLS guidelines was performed at The State 
Department of Health, Albany, New York. 
Results: The level of resistance for fluconazole (FLU) 
and itraconazole (ITRA) among 347 C. glabrata isolates 
was 10.7% and 18.2% respectively. In 33 bloodstream, 
and 314 isolates from other body sites, MICKI for FLU 
was 32.0 Kg/ml and ITRA 1.0 kg/ml. A significant 
difference was observed between isolates from medical 
centers caring for substantial population of patients with 
cancer (Center-I), and AIDS (Center-III) (MI&I for 
FLU 32.0 and >64.0 pg/ml, respectively) and C. glabrata 
isolated from patients at a community-based university 
hospital (Center-II) (MI& for FLU 16.0 kg/ml; 
P=O.OOl). A similar difference for ITRA was not 
significant (P= >0.5). A higher frequency of resistance 
was also noticed among respiratory and urinary tract 
isolates (FLU MI& 264.0 pg/ml). In contract, 46 
isolates obtained from gastrointestinal tract MI&o for 
FLU was ~8.0 kg/ml (P= 0.01). 
Conclusions: The results of present study indicate that 
triazole-derived antifungal susceptibility may not 
significantly differ among C. glabrata associated with 
hematogenous invasion, systemic infection, and colon- 
ization. 
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Introduction: Systemic scedosporiasis due to the 
anamorph/ asexual state of Pseudallescheria boydii has 
emerged as an important cause of opportunistic invasive 
mycosis in the severely immunosuppressed individuals. 
Case report: A 34-year-old man presented with fever 
and hemoptysis, while on oral itraconazole prophylaxis 
8 months after second allogeneic marrow transplant- 
ation for relapsed Philadelphia chromosome positive 
chronic myelogenous leukemia. His WBC was 1400 
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cells/pL. Serum LDH and aminotransferase levels were 
normal. Treatment with AbelcetB (5 mg/kg daily) was 
initiated for bilateral Aspergillus furnigatus invasive 
pulmonary mycosis confirmed by CT scan and bronchial 
cultures. He showed significant improvement during 
2nd week and near-complete resolution of pulmonary 
densities on CT scan. Due to exacerbation of cutaneous 
and orointestinal tract GvHD, the patient was given 
therapy with equine anit-thymocyte globulin, tacrolimus, 
and high-dose methylprednisolone. The 3rd week was 
marked by recurrence of fever (>39”C), and several new 
upper lobe pulmonary lesions. Blood and bronchial 
samples were sterile. Abelcet@ dose was increased (7.5 
mg/kg daily), and oral itraconazole (400 mg liquid every 
8h) was initiated. On 24th day of hospitalization, he 
developed headache, 6th cranial nerve paralysis and 
unsteady wide-based gait. A superior vermian abnor- 
mality including intra-axial cerebellar lesion was noticed 
on magnetic resonance images of brain. Abelcet@ was 
increased to 10 mg/kg daily. He developed progressive 
weakness, obtundation, and died on hospital day 36. 
On postmortem examination a large necrotic abscess 
involving the cerebellar vermis that extended into 
posterior brain stem was seen. Branching, septate hyphal 
elements extending from cerebellar blood vessels were 
seen on histological examination, and S. apiospermum 
was isolated within 72 h. Antifungal susceptibility (MIC 
pg/ml) included: amphotericin B > 16.0; flucytosine 
>64.0; fluconazole 32.0; itraconazole 2.0; ketoconazole 
0.5; and voriconazole 0.5. Cerebellum tissue bioassay for 
free amphotericin B showed levels co.25 rJ,g/ml. 
Conclusions: Breakthrough invasive mycosis due to 
amphotericin B non-susceptible fungi is increasing. 
The newer broad-spectrum triazole-based agents with 
excellent central nervous penetration may significantly 
improve treatment options in patients at risk. 
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Blood stream infections (BSI) are a significant cause of 
morbidity and mortality among patients with cancer 
undergoing therapy. We evaluated all BSI which 
occurred in cancer patients at our institution during 
2000-01 in order to identify the causative pathogens. 
Nosocomial BSI was defined as symptoms and at 
least 2 positive blood cultures for coagulase-negative 
Staphylococcus (CONS) and other skin contaminants 
and one or more positive blood cultures for all other 
pathogens. 
A total of 399 episodes of BSI occurred in 273 patients. 
Of these patients hematological cancer (HC) was 
present in 104 and solid cancers (SC) in 169. Gram- 
positive pathogens were isolated in 221 (55%) of the 
BSI, gram-negatives in 161(40%) and candida spp. in 17 
(5%). Overall, the commonest pathogens isolated were 
S aureus 72 (18%) CONS 63 (16%) Klebsiella spp. 39 
(10%) E. coli 39 (10%) Enterococcus 33 (8%) 
Pseudomonas spp. 24 (6%) , viridans streptococci 22 (6%) 
Enterobacter spp. 18 (5%) Corynebacterium spp. 
11(3%), and S. pneumoniae 9 (2%). Among HC the 
predominant organisms were S aureus 20%) CONS 16%) 
Enterococcus 10%) Pseudomonas 9%, Klebsiella 7 % and 
S pneumoniae 3%. In SC the commonest organisms 
were S aureus 18%, CONS 16%, E.coli 14%, Klebsiella 
13 % , Enterococcus 7%) viridans streptococci 6 %, 
Candida 6%) and Pseudomonas 3%. Twenty-eight 
(27%) of the HC patients vs 29 (17%) of SC patients 
were neutropenic at the time of the BSI. In HC patients 
with neutropenia there were 41 episodes of BSI and the 
commonest organisms were Pseudomonas 17%, CONS 
17%, Enterococcus 12%, S. aureus 9%, Candida 7% and 
E. coli 7%. In contrast of the 34 episodes of BSI in SC 
patients with neutropenia the commonest organisms 
were E. coli 32%, Klebsiella 14%, S. aureus 12%, CONS 
9%, Pseudomonas 6%, and Acinetobacter 6%. 
Gram-positive pathogens were the commonest patho- 
gens isolated from BSI in cancer patients. However, 
the gram-negative pathogens such as E. coli, Klebsiella, 
and Pseudomonas are still significant causes of BSI 
especially among patients with neutropenia. Moreover, 
Pseudomonas still remains the most common pathogen 
isolated from BSI in HC patients with neutropenia. 
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Introduction: A clinical audit was carried out over 5 
years (1997-2001) in the immunocompromised patients 
including neutropenic patients and bone marrow 
(autograft) transplant recipients in hematology ward 
of Gartnaval General Hospital, Glasgow, a tertiary care 
center. 
Objective: It was aimed to establish the degree of 
correlation between bacterial isolates in oro-pharyngeal 
screen during bacteraemia episodes and role of anti- 
biotic prophylaxis. 
Methods: 2191 specimens from 255 patients with 
bacteraemia episodes were screened. 
Results: 29.4% (75/255) incidence of positive cor- 
relation, and 38.4% (981255) of negative correlation 
was observed. There was 32.1% (82/255) incidence of 
coagulase negative staphylococcus (CNS) bacteraemia. 
